These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11150581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
    Holm B, Nilsen DW, Kierulf P, Godal HC.
    Thromb Res; 1985 Jan 01; 37(1):165-76. PubMed ID: 3983897
    [Abstract] [Full Text] [Related]

  • 4. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
    Lipinska I, Lipinski B, Gurewich V, Hoffmann KD.
    Am J Clin Pathol; 1976 Dec 01; 66(6):958-66. PubMed ID: 998569
    [Abstract] [Full Text] [Related]

  • 5. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
    Lipinski B, Lipinska I.
    Magnes Res; 2000 Dec 01; 13(4):233-7. PubMed ID: 11153893
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
    Dempfle CE, Pfitzner SA, Schott D, Niessen KH, Heene DL.
    Thromb Haemost; 1997 May 01; 77(5):879-83. PubMed ID: 9184396
    [Abstract] [Full Text] [Related]

  • 7. Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
    Holm B, Godal HC.
    Thromb Res; 1984 Aug 01; 35(3):279-90. PubMed ID: 6431629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE, Keller A, Argirion S, Heene DL.
    Thromb Haemost; 1999 Feb 01; 81(2):264-7. PubMed ID: 10064004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma HMW fibrinogen in patients with ischaemic heart disease.
    Munkvad S, Nieuwenhuizen W, Jespersen J.
    Scand J Clin Lab Invest; 1990 May 01; 50(3):347-9. PubMed ID: 2353165
    [Abstract] [Full Text] [Related]

  • 14. Half life and incorporation into venous thrombi of the normally occurring plasma fibrinogen fractions HMW and LMW.
    Holm B, Nilsen DW, Godal HC.
    Thromb Res; 1986 Jan 01; 41(1):57-66. PubMed ID: 3961727
    [Abstract] [Full Text] [Related]

  • 15. Plasma fibrinogen.
    Lowe GD, Rumley A, Mackie IJ.
    Ann Clin Biochem; 2004 Nov 01; 41(Pt 6):430-40. PubMed ID: 15588432
    [Abstract] [Full Text] [Related]

  • 16. Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
    de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR.
    Thromb Res; 1995 May 15; 78(4):353-62. PubMed ID: 7631315
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clauss assay and fibrinogen protein estimated by capillary zone electrophoresis.
    Lebitasy MP, Latinne D, Maisin D, Vertommen D, Eeckhoudt S.
    Clin Chem Lab Med; 2011 Apr 15; 49(4):689-93. PubMed ID: 21288173
    [Abstract] [Full Text] [Related]

  • 20. Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease.
    Lipinski B, Lipinska I, Nowak A, Gurewich V.
    J Lab Clin Med; 1977 Jul 15; 90(1):187-94. PubMed ID: 406338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.